Filter
5
Filtered Results: 5
Text search:
G.H.
Wills,
E.
Wobudeya,
et
al.
Featured
Recommendations
3
Language
Document type
No document type
2
Studies & Reports
1
Guidelines
1
Fact sheets
1
Countries / Regions
Africa
1
India
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
3
Key Resources
1
Toolboxes
TB
4
HIV
1
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six months treatment for children with minimal TB
